PMGC Holdings ELAB
NASDAQ ELAB
$4.70 +0.08 (+1.62%)
As of: Sep 10, 2026 · 11:58 AM EDT

PMGC Holdings (ELAB) Price to Sales (2023 - 2026)

PMGC Holdings' (ELAB) quarterly Price to Sales came in at 0.45 in Q2 2026, up 15.67% quarter-over-quarter from 0.39 in Q1 2026.

Analysis

PMGC Holdings (ELAB) Price to Sales (2023 - 2026) Analysis & Trends

PMGC Holdings has disclosed Price to Sales across 4 years of filings, most recently posting 0.45 for Q2 2026.

  • In Q2 2026, Price to Sales changed N/A year-over-year to 0.45; the TTM figure through Jun 2026 stood at 0.23 (changed 0.34% YoY), while the FY2025 annual figure was 0.12, up 136.27% from the prior year.
  • Price to Sales came in at 0.45 for Q2 2026 at PMGC Holdings, up from 0.39 in the prior quarter.
  • In the past five years, Price to Sales ranged from a high of 562.58 in Q4 2023 to a low of 0.18 in Q4 2024.
  • Average Price to Sales over 4 years is 138.04, with a median of 1.32 recorded in 2025.
  • Year-over-year, Price to Sales plunged 99.97% in 2024 and jumped 33.72% in 2025.
  • Over 4 years, Price to Sales stood at 562.58 in 2023, then sank by 99.97% to 0.18 in 2024, then jumped by 33.72% to 0.24 in 2025, then jumped by 90.01% to 0.45 in 2026.
  • Per Business Quant data, the three most recent Price to Sales figures were 0.45 in Q2 2026, 0.39 in Q1 2026, and 0.24 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 207.26 Bn 193.27 Bn 7.24 Bn
2 Gilead Sciences 179.66 Bn 176.48 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.52 Bn 123.67 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.77 Bn 73.78 Bn 3.93 Bn
5 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
6 Moderna 53.55 Bn 48.41 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.38 Bn 30.07 Bn 992.69 Mn
8 Biogen 31.68 Bn 30.40 Bn 1.96 Bn
9 Roivant Sciences 29.12 Bn 29.12 Bn 1.16 Mn
10 PMGC Holdings 2.29 Mn -16.50 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.45
Mar 31, 2026 0.39
Dec 31, 2025 0.24
Sep 30, 2025 0.98
Mar 31, 2025 1.65
Dec 31, 2024 0.18
Sep 30, 2024 60.12
Jun 30, 2024 361.92
Mar 31, 2024 391.93
Dec 31, 2023 562.58